Investors

EKF Diagnostics Holdings plc comprises established businesses with operations in the UK, Ireland, Germany, Poland and Russia (where EKF holds 60 per cent of the issued share capital of the local entity).

The business is focused on the design, development, manufacture and selling of diagnostic instruments and reagents. EKF Diagnostics also sells ancillary products including a line of proprietary cuvettes (small transparent containers which contain the patients’ specimen in the device).

EKF Diagnostics' products and devices are designed to meet the needs of smaller professional clinical and research laboratories, doctors’ offices, sports clinics and athletic testing sites. The Group has its own sales force and is particularly strong in Eastern Europe and Russia which, the Directors believe, represent significant untapped point of care markets.

In 2010 EKF Diagnostic Holdings plc acquired Quotient Diagnostics Limited, based in Walton-on-Thames in Surrey and Argutus Medical Limited, based in Dublin, Ireland. The addition of these two businesses demonstrates the ambition of EKF to becoming a world leader in point of care diagnostics in hematology and kidney related diseases.

In June 2011 EKF Diagnostics acquired US manufacturer and distributor Stanbio Laboratory and also announced a distribution agreement with Alere for the Hemo Control blood analyser (sold as HemoPoint in the USA and Mexico).